期刊文献+

一种高效快速肺炎球菌多糖蛋白结合疫苗纯化方法的建立 被引量:4

An effective and rapid purification method for pneumococcal capsular polysaccharide-protein conjugate vaccine
原文传递
导出
摘要 目的建立一种高效快速肺炎球菌多糖蛋白结合疫苗CPS9V-CRM_(197)的纯化方法。方法将9V型肺炎球菌多糖(CPS9V)与载体蛋白(CRM197)通过胺还原法进行偶连结合,制备成多糖蛋白结合物CPS9V-CRM_(197)。通过超滤及阴离子层析两步法纯化后,经皮下免疫BALB/c小鼠,5μg/只,首次免疫后14d进行第2次免疫。于末次免疫后0、7、14、21d经颈动脉采血,分离血清,ELISA法检测血清中的IgG及IgM抗体滴度。结果纯化的CPS9V-CRM_(197)结合物纯度达100%,多糖的总回收率为95%,分子半径为8.4nm,CL-4B色谱洗脱体积为50.32ml,酶解敏感性高于载体蛋白CRM197。末次免疫后7、14、21d时,CPS9V-CRM_(197)免疫小鼠血清中IgG及IgM的滴度均明显高于CPS9V组(P<0.05)。结论本实验建立的肺炎多糖结合物两步纯化法具有高效、快速等优点,可用于进一步提高实际工业化生产中的生产效率。 Objective To develop a highly effective and rapid purification method for pneumococcal capsular poly-saccharide-protein conjugate CPS9V-CRM(197). Methods The capsular polysaccharide of Steptococcus pneumonia type 9V(CPS9V) was conjugated to carrier protein CRM197 by amine reduction. The prepared conjugate CPS9V-CRM(197) was purified by ultrafiltration and anion-exchange chromatography, with which BALB/c mice were immunized s. c. at a dosage of 5 μg for 2 times at an interval of 14 d. The serum samples of mice were collected 0, 7, 14 and 21 d after the second immunization and determined for Ig G and Ig M titers by ELISA. Results The purified CPS9V-CRM(197) conjugate reached a purity of 100%. The total recovery rate of polysaccharide was 95%, while the molecular radius was 8. 4 nm, and the elution volume of CL-4B chromatography was 50. 32 ml. The sensitivity of the conjugate to enzyme digestion was higher than that of CRM197. Both the Ig G and Ig M titers in sera of mice 7, 14 and 21 d after the second immunization with CPS9V-CRM(197) conjugate were significantly higher than those with CPS9V(P 〈 0. 05). Conclusion The developed twostep purification method for pneumococcal capsular polysaccharide-protein conjugate was effective and rapid, which might be used for further improvement of efficacy of industrial production.
出处 《中国生物制品学杂志》 CAS CSCD 2017年第7期764-768,共5页 Chinese Journal of Biologicals
关键词 肺炎球菌多糖 载体蛋白 结合疫苗 纯化 免疫原性 Pneumococcal capsular polysaccharide Carrier protein Conjugate vaccine Purification Immunogenicity
  • 相关文献

参考文献2

二级参考文献23

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:606
  • 2管远志 陆德如.细菌形态与结构.医学微生物学(第4版)[M].人民卫生出版社,1995.18-19.
  • 3焦炳华 焦炳华.细菌内毒素的化学结构.细菌内毒素学[M].上海科学技术文献出版社,1995.19-55.
  • 4O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates[J]. Lancet, 2009, 374 (9693): 893-902.
  • 5World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper [J]. Weekly Epidemiol Rec, 2007, 82 (12) : 93-104.
  • 6Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [J]. MMWR Recomm Rep, 2000, 49 (RR-9) : 1-35.
  • 7UNICEF/WHO. Pneumonia: The forgotten killer of children [J]. Weekly Epidemiol Rec, 2008, 83: 1-16.
  • 8Baraff L J, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis [J]. Pediatr Infect Dis J, 1993, 12(5):389-394.
  • 9Felmingham D, White AR, Jacobs MR, et al. The alexander project: the benefits from a decade of surveillance [J]. J Antimicrob Chemother, 2005, 56 (Suppl 2): 113-1121.
  • 10Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study) [J]. Antimicrob Agents Chemother, 2004, 48 (6) : 2101-2107.

共引文献14

同被引文献45

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部